Iterum TherapeuticsITRMF
13F holders, Q4 2025 (December 31)4holders
0new positions
0sold out
$0.34avg. 13F price*
At the end of Q4 2025, 4 institutions reported holding Iterum Therapeutics PLC (ITRMF) in their 13F filings, unchanged from Q3 2025. 0 opened new positions and 0 sold out. The largest holders were Captrust Financial Advisors ($46K), Gen-Wealth Partners Inc ($28K) and Blue Bell Private Wealth Management, LLC ($22).
- Company
- Iterum Therapeutics PLC
- CUSIP
- G6333L101
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q3 2025 → Q4 2025: 29,583 shares bought, net +29,583 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Captrust Financial Advisors | 0.00% | Add +24.2% | 138,600 | $46K |
| Gen-Wealth Partners Inc | 0.01% | Add +3.1% | 84,630 | $28K |
| Blue Bell Private Wealth Management, LLC | 0.00% | No change | 66 | $22 |
| Cypress Capital Management LLC (WY) | 0.00% | No change | 66 | $22 |
"% of holder's portfolio" is ITRMF's weight in each manager's 13F, not the share of Iterum Therapeutics PLC the manager owns.